Early fractional carbon dioxide laser intervention for postsurgical scars in skin of color
Received 19 June 2018
Accepted for publication 26 June 2018
Published 4 January 2019 Volume 2019:12 Pages 29—34
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Dr Jeffrey Weinberg
Shady M Ibrahim,1 Wael M Saudi,2 Mohamed F Abozeid,3 Mohamed L Elsaie4
1Department of Dermatology, Al Azhar University, Cairo, Egypt; 2Department of Dermatology, Misr University for Science & Technology, 6th of October City, Egypt; 3Department of Plastic surgery, Cairo University, Giza, Egypt; 4Department of Dermatology, National Research Centre, Cairo, Egypt
Background: Fractional CO2 laser is one of the most effective treatment options used to resurface scars.
Objective: To evaluate the efficacy and safety of early treatment of postsurgical scar by fractional ablative CO2 laser.
Methods: A total of 27 Egyptian patients with recent postoperative scars were enrolled in this study. Three sessions of fractional CO2 laser with a 1-month interval were started 4 weeks after surgery. Vancouver Scar Scale (VSS) was used as an assessment tool at 1 and 3 months after the final treatment. Patients reported their satisfaction using a subjective 4-point scale.
Results: Results demonstrated a statistically significant overall average improvement of the VSS (5.33±1.33) before compared with (2.55±1.06) 3 months after the last laser treatment (P≤0.001). Among the individual parameters in the VSS, the most significant improvements were found in pigmentation, height, and pliability. Patient’s subjective satisfaction scores showed a significant greater degree of satisfaction after laser treatment.
Conclusion: Fractional ablative CO2 laser is an effective and safe treatment modality for surgical scars in the early postsurgical period.
Keywords: scar, fractional, CO2 laser
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]